Experiment 973916
Compounds isolated
Details
| Property | Value |
|---|---|
| Pharmacology | |
| Administration route | IV INFUSION |
| Organism | Empty organism |
| Citation | YAP,HY: MURPHY,WK: DISTEFANO,A: BLUMENSCHEIN,GR: BODEY,GP:. (1979). PHASE II STUDY OF ANGUIDINE IN ADVANCED BREAST CANCER.. 63() |
| Amount utilized | |
| Compound isolated | |
| Disease | 30 PATIENTS WITH ADVANCED REFRACTORY BREAST CANCER WERE INVOLVED IN THIS PHASE 2 STUDY. PATIENTS IN THE STUDY WERE GIVEN DOSAGE DAILY FOR 5 DAYS EVERY 3 WEEKS. TOXICITIES INCLUDED NAUSEA, VOMITING, FEVER, CHILLS, SKIN ERYTHEMA, SOMNOLENCE, CONFUSION, LETHARGY WITH HYPOTENSION BEING THE MOST SIGNIFICANT SIDE EFFECT. MYELOSUPPRESSION WAS MINIMAL. ONE PATIENT WAS A PARTIAL RESPONDER AND 1 SHOWED IMPROVEMENT (LESS THAN A PARTIAL RESPONSE). |
| Dose amount | 5.0 MG |
| Number | 1 |
| Qualitative result | . |
| Animal | HUMAN ADULT |
| Per unit | SQ M |
| Dose expression | DOSE |